Advertisement

Sucralfate pp 249-255 | Cite as

Therapy of Active Duodenal Ulcers

  • Francois Martin

Abstract

In 1977, cimetidine had just been released in Canada for the treatment of duodenal ulcers. In view of this powerful acid-suppressing drug, Schwarz’s time-honored dictum “No acid, no ulcer” never seemed more appropriate! The high healing rates of active duodenal ulcers, combined with the rapid relief of ulcer symptoms obtained by treating patients with cimetidine over a short period of 6 to 8 weeks, largely explain the rapid, universal acceptance of this new therapeutic breakthrough for peptic ulcer patients.

Keywords

Duodenal Ulcer Peptic Ulcer Disease Ulcer Healing Duodenal Ulcer Patient Healing Capacity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hollander D: A multicenter, double-blind trial of sucralfate in duodenal ulcer therapy. Scand J Gastroenterol 18(suppl 83):25–30, 1983.Google Scholar
  2. 2.
    McHardy GG: A multicenter, double-blind trial of sucralfate and placebo in duodenal ulcer. J Clin Gastroenterol 3(suppl 2):147–152, 1981.PubMedGoogle Scholar
  3. 3.
    Moshal MG, Spitaels JM, Kahn F: Sucralfate in the treatment of duodenal ulcers: A double blind endoscopically controlled trial. S Afr Med J 57:742–744, 1980.PubMedGoogle Scholar
  4. 4.
    Elliot C, Orchard R: A double-blind placebo controlled study of sucralfate in the treatment of gastric and duodenal ulcer. Hepatogastroenterology 27(suppl):384, 1980.Google Scholar
  5. 5.
    Lathinen J, Ala-Kaila, Aukae S, et al: Sucralfate and antacid in the treatment of gastric and duodenal ulcer. The preliminary report of a multicenter double-blind trial, in Caspary WF (ed): Duodenal Ulcer, Gastric Ulcer: Sucralfate, a New Therapeutic Concept. Munich, Urban &0026; Schwarzenberg, 1981, pp 111–115.Google Scholar
  6. 6.
    Fixa B, Komarkova O: Aluminum sucrose sulfate (sucralfate) in the treatment of peptic ulcer (double-blind study), in Caspary WF (ed): Duodenal Ulcer, Gastric Ulcer; Sucralfate, a New Therapeutic Concept. Munich, Urban &0026; Schwarzenberg, 1981, pp 80–84.Google Scholar
  7. 7.
    Orchard R, Elliot C: A double-blind placebo-controlled study of sucralfate in the treatment of gastric and duodenal ulcer, in Caspary WF (ed): Duodenal Ulcer. Gastric Ulcer: Sucralfate, a New Therapeutic Concept. Munich, Urban &0026; Schwarzenberg, 1981, pp 85–88.Google Scholar
  8. 8.
    Sung JL, Yu JY, Yang TH, et al: A placebo-controlled, double-blind study of sucralfate in the shortterm treatment of duodenal ulcer. Scand J Gastroenterol 19(suppl 83):21–24, 1983.Google Scholar
  9. 9.
    Elsborg L, Boysen K, Brunsgaard A, et al: Sucralfate vs placebo treatment in duodenal and prepyloric ulcer: A clinical endoscopic, double-blind controlled investigation. Hepatogastroenterology 31:269–271, 1984.PubMedGoogle Scholar
  10. 10.
    Martin F: Multicenter study group. Sucralfate suspension 1 g four times per day in the short-term treatment of active duodenal ulcer. Am J Med 86(suppl 6A):104–107, 1989. In Refs. 1 to 10 inclusive, reports are presented on placebo-controlled studies of sucralfate in duodenal ulcers. In these 878 treated patients, the mean % healing rate for sucralfate was 75.4% versus placebo 48.1%. Very few side effects were observed in these studies.PubMedCrossRefGoogle Scholar
  11. 11.
    Marks IN, Wright JP, Denyer M, et al: Comparison of sucralfate and cimetidine in the short-term treatment of chronic peptic ulcers. S Afr Med J 57:567–573, 1980.PubMedGoogle Scholar
  12. 12.
    Martin F, Farley A, Gagnon M, et al: Comparison of the healing capacities of sucralfate and cimetidine in the short-term treatment of duodenal ulcer: A double-blind randomized trial. Gastroenterology 82:401–405, 1982.PubMedGoogle Scholar
  13. 13.
    Guslandi M, Bakkarubm E, Tittobello A: Ulcer healing and mucosa stimulation properties of sucralfate: A study comparing sucralfate to cimétidine. Fortschr Med 100:1778–1780, 1982.PubMedGoogle Scholar
  14. 14.
    Hentschel E, Schutze K, Dufek W: Controlled comparison of sucralfate and cimetidine in duodenal ulcer. Scand J Gastroenterol 18(suppl 83):31–35, 1983.Google Scholar
  15. 15.
    Pop P, Nikkers RE, Thye O, et al: Comparison of sucralfate and cimetidine in the treatment of duodenal and gastric ulcer. A multicenter study. Scand J Gastroenterol 18(suppl 83):43–47, 1983.Google Scholar
  16. 16.
    Van Deventer GM, Schneidman D, Walsh JH: Sucralfate and cimetidine as single agents and in combination for treatment of active duodenal ulcers: A double-blind placebo-controlled trial. Am J Med 79(suppl 2C):39–41, 1985.Google Scholar
  17. 17.
    Glise H, Carling L, Hallerback B, et al: Short term treatment of duodenal ulcer. A comparison of sucralfate and cimetidine. Scand J Gastroenterol 21:313–320, 1986.PubMedCrossRefGoogle Scholar
  18. 18.
    Lam SK, Hut WM, Lau WY, et al: Sucralfate overcomes adverse effect of cigarette smoking on duodenal ulcer healing and prolongs subsequent remission. Gastroenterology 92:1193–1201, 1987.Google Scholar
  19. 19.
    Rey JF, Legras B, Verdier B, et al: Comparative study of sucralfate versus cimetidine in the treatment of acute gastroduodenal ulcer: Randomized trial on 667 patients. Am J Med 86(suppl 6A):116–121, 1989.PubMedCrossRefGoogle Scholar
  20. 20.
    Tovey FI, Husband EM, Yiu YC, et al: Comparison of relapse rates and of mucosal abnormalities after healing of duodenal ulceration and after one year’s maintenance with cimetidine or sucralfate: A light and electron microscopy study. Gut 30:586–593, 1989. In Refs. 11 to 20 inclusive, reports of comparative trials of sucralfate versus cimetidine in the short-term treatment of duodenal ulcers are presented. In these 1501 treated patients, the pooled average healing rates were 74.5% for sucralfate and 74.6% for cimetidine. Also, the healing rates for sucralfate in these comparative trials were similar to those observed in the placebo-controlled studies, namely 75.5%.PubMedCrossRefGoogle Scholar
  21. 21.
    Koelz HR, Halter F: Ulcer study group. Sucralfate and ranitidine in the treatment of acute duodenal ulcer: Healing and relapse. Am J Med 86(suppl 6A):98–103, 1989. In this study the comparative efficacy of sucralfate and ranitidine was tested for the short-term treatment of duodenal ulcers, and an identical healing rate of 74% was found in the two treatment groups.PubMedCrossRefGoogle Scholar
  22. 22.
    Tarnawski A, Hollander D, Gergely H: The mechanism of protective, therapeutic and prophylactic actions of sucralfate. Scand J Gastroenterol 22(suppl 140):7–13, 1987. This article summarizes the gastroduodenal mucosal protection mechanisms by which sucralfate exerts its ulcer healing capacities.Google Scholar
  23. 23.
    Lam SK: Why do ulcers heal with sucralfate? Scand J Gastroenterol 25(suppl 173):6–13, 1990. With several other mechanisms related to the healing capacity of sucralfate, the specific issue of smoking and duodenal ulcer healing is specifically addressed in this article, and the author reports that on more than 500 pooled patients 78.4% of smokers and 77.6% of nonsmokers healed on sucralfate.CrossRefGoogle Scholar
  24. 24.
    Lam SK: Treatment of duodenal ulcer with sucralfate. Scand J Gastroenterol 26(suppl 185):22–28, 1991. In this article the author submits evidence to support the advantages of sucralfate over conventional H2RAs in the short-term treatment of duodenal ulcers and for the increase in the posthealing remission length.CrossRefGoogle Scholar
  25. 25.
    Shreeve DR, Klass HJ, Jones PE: Comparison of cimetidine and tripotassium dicitrato bismuthate in healing and relapse of duodenal ulcers. Digestion 28:96–101, 1983.PubMedCrossRefGoogle Scholar
  26. 26.
    Hamilton I, O’Connor HJ, Wood NC, et al: Healing and recurrence of duodenal ulcer after treatment of dicitrato bismuthate (TCB) tablets or cimetidine. Gut 27:105–110, 1986.Google Scholar
  27. 27.
    Martin DF, Hollander D, May SJ, et al: Difference in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1:7–10, 1981. In Refs. 25 to 27 inclusive, comparative studies are reported where a longer period of remission seems to follow initial treatment with colloidal bismuth when compared with cimetidine; approximately 25% more patients are still in remission after 1 year when initially treated with sucralfate.PubMedCrossRefGoogle Scholar
  28. 28.
    Domschke S: Longer relapse-free period after acute treatment with sucralfate than after H2-blocker in peptic ulcer patients. 6th International Sucralfate Symposium Abstracts, ADIS Press, 1990, p 28.Google Scholar

Copyright information

© Plenum Press 1995

Authors and Affiliations

  • Francois Martin
    • 1
  1. 1.Division of GastroenterologyHopital Saint-Luc, and University of MontrealMontrealCanada

Personalised recommendations